Navigation Links
Blau, Brown & Leonard, LLC Settlements Near Two Million Dollars on Behalf of Women who Endured DVT's, PE's and Strokes from Yaz, Yasmin and Ocella
Date:12/13/2012

d, LLC" onclick="linkClick(this.href)">Blau, Brown & Leonard, LLC

Blau, Brown & Leonard, LLC is a law firm representing women nationwide who have been injured by Yaz, Yasmin, Ocella or BeYaz. The firm has a toll free number dedicated to educating women about their rights in this litigation at (800) YAZ-0287. Blau, Brown & Leonard, LLC is a formidable team of trial attorneys who have experience working mass torts and many million dollar settlements and judgments on behalf of their clients. Managing Partner Jason T. Brown was a former Special Agent and Legal Adviser to the Federal Bureau of Investigation (FBI) and is lead counsel in class actions all over the country. Often times, Mr. Brown will field calls and questions directly. There is no fee unless the firm is successful with the case.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10192800.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lifespan/Tufts/Brown Center for AIDS Research renewed with $8.5 million NIH grant
2. Beige Fat Joins Brown Fat as Potential Weight-Loss Target
3. Research shows efficacy of treatment model developed at Women & Infants
4. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
5. Vendors in Nevada, Michigan, & Illinois to be Featured on the PartyPOP.com Online Network
6. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
7. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
8. Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
9. Play & Park Structures Included in New Play for All Abilities Playground
10. Gum Disease, HPV May Play Role in Head & Neck Cancers
11. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 GI for Life announced today, ... in prices of their popular nutritional supplements: ColoVite ... . Discounts of 40% will be offered for ... Life’s proprietary ColoVite supplement is a scientifically formulated vitamin ... health. One easy-to-take colon vitamin with ALL the nutrients ...
(Date:11/26/2014)... Albany, NY (PRWEB) November 26, 2014 ... industry research requirements or email the details on sales(at)researchmoz(dot)us ... "Worldwide diabetes and drug discovery market 2014" with deep ... Diabetes is the result of high blood sugar. The ... is directly linked to the growing number of diabetics ...
(Date:11/26/2014)... 26, 2014 News Facts , ... capabilities at RSNA 2014 in Chicago. The company ... share diagnostic images, photos, videos and documents found ... #8107 will learn more about these innovative medical ... and partner initiatives – that enable more informed ...
(Date:11/26/2014)... -- Teens prescribed anti-anxiety or sleep medications are ... other teens, a new study warns. The ... assessments on teenagers before prescribing these drugs to ... don,t realize the abuse potential," said lead researcher ... Michigan School of Nursing. "These drugs produce highly ...
(Date:11/26/2014)... -- Parents need to take an active role in ... Parents must make sure sports-playing teens have the ... chair of the American Migraine Foundation and a professor ... in Scottsdale, Ariz. in an American Migraine Foundation, said ... involved with teens sports needs to have appropriate training. ...
Breaking Medicine News(10 mins):Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2
... , MONDAY, May 21 (HealthDay News) -- The new blood ... blood clots in high-risk heart patients, a U.S. Food and ... briefing documents that were filed Monday in advance of an ... to vote on whether to recommend approval of Xarelto for ...
... HealthDay Reporter , MONDAY, May 21 (HealthDay News) -- ... helps overweight women lower the levels of certain hormones in ... breast cancer. The findings don,t ... Still, women who take medications to prevent the disease "need ...
... By Steven Reinberg HealthDay Reporter , MONDAY, ... be reducing their risk of psoriasis, Harvard University researchers report. ... scaly patches on the skin. Vigorous activity for ... risk by 25 percent to 30 percent, the researchers said. ...
... scientist from the Viral Immunology Center at Georgia State ... of the eye is associated with neovascular age-related macular ... elderly. The scientists found that human cytomegalovirus, a ... growth factor, or VEGF, a signal protein that regulates ...
... A team of scientists has developed a promising new ... shrink and die. The researchers hope that their discovery ... drug that effectively targets unhealthy, cancerous tissue without damaging ... be published in the Journal of Biological Chemistry ...
... went to John Edward Solder, a senior at Staples ... Interrogation of Prefrontal Cortex Dopamine D1 Receptor-Containing Neurons as ... Treat Prefrontal Disorders. The 18-year-old was able to specifically ... to activate dopamine neurons in the prefrontal cortex, a ...
Cached Medicine News:Health News:New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA 2Health News:Dieting May Lower Hormone Levels Tied to Breast Cancer 2Health News:Vigorous Exercise Might Keep Psoriasis at Bay 2Health News:Vigorous Exercise Might Keep Psoriasis at Bay 3Health News:Type of viral infection of eye associated with disease causing blindness in the elderly 2Health News:Strategy discovered to activate genes that suppress tumors and inhibit cancer 2Health News:Strategy discovered to activate genes that suppress tumors and inhibit cancer 3Health News:Optogenetics project takes top NIDA Addiction Science Award 2Health News:Optogenetics project takes top NIDA Addiction Science Award 3Health News:Optogenetics project takes top NIDA Addiction Science Award 4
(Date:11/26/2014)... Pa. , Nov. 25, 2014  Unilife Corporation ... of injectable drug delivery systems, today announced that its ... to present at the Piper Jaffray 26th Annual Healthcare ... a.m. EST on Tuesday, December 2, 2014. ... Internet as a "live" listen only Webcast. To listen, ...
(Date:11/26/2014)... and LONDON , Nov. 25, 2014 /PRNewswire/ ... AZN ) today announced that AMAGINE-2 TM , ... brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, ... (ustekinumab) and placebo at week 12. Brodalumab 210 mg ... were each shown to be superior to Stelara on the ...
(Date:11/26/2014)... DIEGO , Nov. 25, 2014 Halozyme Therapeutics, ... the Piper Jaffray Healthcare Conference in New York ... EDT/10:00 a.m. PDT . Dr. Helen Torley , ... The presentation will be webcast through the "Investors" ... a recording will be made available for 90 days following ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... Delcath Systems, Inc. (Nasdaq: DCTH ) ... Senior Vice President of Medical Device Research and Development ... to the position of Vice President of Pharmaceutical Research ... based in the Company,s Queensbury, New York facility and ...
... Thomson Reuters, a global provider of information ... version of its award-winning Clinical Xpert Navigator ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090507/NY12658LOGO) (Logo: http://photos.prnewswire.com/prnh/20090507/NY12658LOGO) ... to access complete patient clinical data — ...
Cached Medicine Technology:Delcath Strengthens Research and Development Team with Key Appointments 2Delcath Strengthens Research and Development Team with Key Appointments 3Thomson Reuters Releases iPhone Support for Clinical Xpert Navigator 2Thomson Reuters Releases iPhone Support for Clinical Xpert Navigator 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: